Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/44223
Title: Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis.
Author: Miró Meda, José M.
Manzardo, Christian
Mussini, C.
Johnson, Margaret M.
D'Arminio Monforte, Antonella
Antinori, A.
Gill, M.J.
Sighinolfi, L.
Uberti-Foppa, C.
Borghi, V.
Sabin, C.
Late Presenters Investigators.
Keywords: VIH (Virus)
Sida
Antiretrovirals
Terapèutica
Persones seropositives
HIV (Viruses)
AIDS (Disease)
Antiretroviral agents
Therapeutics
HIV-positive persons
Issue Date: 17-Oct-2011
Publisher: Public Library of Science (PLoS)
Abstract: Objectives: We analyzed clinical progression among persons diagnosed with HIV at the time of an AIDS-defining event, and assessed the impact on outcome of timing of combined antiretroviral treatment (cART). Methods: Retrospective, European and Canadian multicohort study.. Patients were diagnosed with HIV from 1997-2004 and had clinical AIDS from 30 days before to 14 days after diagnosis. Clinical progression (new AIDS event, death) was described using Kaplan-Meier analysis stratifying by type of AIDS event. Factors associated with progression were identified with multivariable Cox regression. Progression rates were compared between those starting early (< 30 days after AIDS event) or deferred (30-270 days after AIDS event) cART. Results: The median (interquartile range) CD4 count and viral load (VL) at diagnosis of the 584 patients were 42 (16, 119) cells/ mL and 5.2 (4.5, 5.7) log 10 copies/mL. Clinical progression was observed in 165 (28.3%) patients. Older age, a higher VL at diagnosis, and a diagnosis of non-Hodgkin lymphoma (NHL) (vs. other AIDS events) were independently associated with disease progression. Of 366 patients with an opportunistic infection, 178 (48.6%) received early cART. There was no significant difference in clinical progression between those initiating cART early and those deferring treatment (adjusted hazard ratio 1.32 [95% confidence interval 0.87, 2.00], p=0.20). Conclusions: Older patients and patients with high VL or NHL at diagnosis had a worse outcome. Our data suggest that earlier initiation of cART may be beneficial among HIV-infected patients diagnosed with clinical AIDS in our setting.
Note: Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0026009
It is part of: PLoS One, 2011, vol. 6, num. 10, p. e26009
Related resource: http://dx.doi.org/10.1371/journal.pone.0026009
URI: http://hdl.handle.net/2445/44223
ISSN: 1932-6203
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
610259.pdf297.69 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons